Investment Banking
Exclusive Financial Advisor to 3 of Rhode Island's Leading Gastroenterology Practices On Sale to GI Alliance
January 24, 2024
Oppenheimer & Co. Inc. acted as Exclusive Financial Advisor to University Gastroenterology, Gastroenterology Associates, and Gastrointestinal Medicine Associates on Sale to Gi Alliance
University Gastroenterology, Gastroenterology Associates, and Gastrointestinal Medicine Associates have been working together to provide better access to patients across Rhode Island and surrounding areas. GI Alliance's partnership with these physicians will expand coverage for patients throughout New England.
Collectively, patients will have the benefit of expanded services across a broader geographic coverage area with greater availability to healthcare, as well as complementary ancillary services including pathology, anesthesia, infusion, and clinical research.
GI Alliance is a physician-led and majority physician-owned GI practice management company providing services to over 800 independent gastroenterologists operating in Arkansas, Arizona, Colorado, Connecticut, Florida, Illinois, Indiana, Kansas, Louisiana, Mississippi, Missouri, Oklahoma, Texas, Utah, Washington, and now Rhode Island. GI Alliance managed practices focus on providing the highest-quality care to their patients. In addition to providing operational support for practices, GI Alliance is working to unite gastroenterologists nationwide by aligning interests and improving patient care.
Name:
Marc Cabrera
Title:Co-Head of Healthcare, Head of Healthcare Services
DISCLOSURES
This notice is provided for informational purposes only, and is not intended as a recommendation or an offer or solicitation for the purchase or sale of any security or financial instrument. Nothing contained herein shall constitute an offer or solicitation to buy or sell any securities discussed herein in any jurisdiction where such offer or solicitation would be prohibited.
This notice may contain statistical data cited from third-party sources believed to be reliable, but Oppenheimer & Co. Inc. does not represent that any such third-party statistical information is accurate or complete, and it should not be relied upon as such. All market prices, data and other information are not warranted as to completeness or accuracy and are subject to change without notice.
2024 Oppenheimer & Co. Inc. Transacts Business on all Principal Exchanges and Member SIPC 6289712.1